RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval, surrogate endpoints, registration Not quite. An Accelerated Approval can be requested as soon as the FDA sees the study protocol and patient enrollment has begun. The Registration Enabling Phase 2 Study satisfies the FDA's protocol requirements and patient enrollment will be a continuation to ONCY's Goblet-1 Phase 2 pancreatic cancer cohort study. thus meeting FDA's requirements for registration and their Accelerated Approval process.